Zhi Dong

Peking University - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing)

SCHOLARLY PAPERS

1

DOWNLOADS

53

TOTAL CITATIONS

1

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

A Phase Ib Study of KN026, a Bispecific Anti-HER2 Antibody, Combined with KN046, an Anti-CTLA-4/PD-L1 Antibody, in Patients with HER2-Positive Advanced Gastrointestinal Cancer

Number of pages: 33 Posted: 07 May 2022
Zhi Dong, Dan Liu, Jifang Gong, Xiaotian Zhang, Suxia Luo, Zhi Peng, Yakun Wang, Changsong Qi, Zhenghang Wang, Jian Li, Xicheng Wang, Ming Lu, Zhihao Lu, Jun Zhou, Yanshuo Cao, Jiajia Yuan and Lin Shen
Peking University - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Zhengzhou University - Henan Cancer Hospital, Peking University - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing) and Peking University - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing)
Downloads 53 (835,737)
Citation 1

Abstract:

Loading...

Gastrointestinal cancer, Bispecific antibody, Anti-HER2 therapy, Immunotherapy.